ATC Abstracts

American Transplant Congress abstracts

2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions
View by Date

Saturday, May 2, 2015

5:30pm-7:30pm
“Unexpected” Positive Crossmatchs in Zero-HLA-A-B-DR Mismatched or HLA-DR-Matched Organs

K. Haarberg,1 M. Cusick,1 M. Abecassis,1 A. Jaramillo,2 B. Kaplan,3 A. Tambur.1

Poster Session A: Kidney Antibody Mediated Rejection  •  Exhibit Hall E
5:30pm-7:30pm
hTERT, BICD1 and Chromosome 18 Polymorphisms Affecting Telomere Length Are Associated With Kidney Transplantation Outcome

L. Domanski,1 K. Kloda,1 K. Safranow,2 A. Drozd,3 K. Ciechanowski,1 A. Ciechanowicz.4

Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis  •  Exhibit Hall E
5:30pm-7:30pm
A 10 Min “No-Touch” Time – Is It Enough in DCD? A DCD Animal Study

M. Sereinigg,1 V. Stadlbauer,2 T. Seifert-Held,3 F. Iberer,1 P. Stiegler.1

Poster Session A: Donor Management: All Organs  •  Exhibit Hall E
5:30pm-7:30pm
A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation

E. Dantan, K. Renaudin, S. Brouard, A. Huneau, C. Paul, M. Giral.

Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis  •  Exhibit Hall E
5:30pm-7:30pm
A Comparison of Alemtuzumab and Antithymocyte Globulin Induction in High-Risk, Non-Sensitized African American Renal Transplant Recipients

M. Janusek,1 S. Patel,2 K. Galen,1 P. West-Thilke,1 E. Benedetti,1 J. Thielke.1

Poster Session A: Kidney Immunosuppression: Induction Therapy  •  Exhibit Hall E
5:30pm-7:30pm
A New Diagnostic and Pronostic Tool for Antibody Mediated Rejection in Kidney Transplantation: Intragraft Donor Specific Anti-HLA Antibodies Detection

J. Olagne,1,2,3 A. Parissiadis,2 S. Caillard,1 N. Froelich,2 L. Marcellin,3 C. Muller,1 G. Gautier-Vargas,1 P. Perrin,1 L. Braun-Parvez,1 F. Heibel,1 C. Gachet,2 B. Moulin.1

Poster Session A: Kidney Antibody Mediated Rejection  •  Exhibit Hall E
5:30pm-7:30pm
A Novel DSA Flow Cytometer Crossmatch (DSA-FXM) to Eliminate Ambiguous Auto- and Allo-FXM Results

G. Chen, L. Lin, D. Tyan.

Poster Session A: Kidney Antibody Mediated Rejection  •  Exhibit Hall E
5:30pm-7:30pm
A Novel Maintenance Regimen With Calcineurin Inhibitor, MMF and Everolimus Initiated By Dual Induction Therapy With Anti-CD20/25 Antibodies in Renal Transplantation

N. Masaki, K. Iwado, I. Nakagima, S. Fuchinoue.

Poster Session A: Kidney Immunosuppression: Induction Therapy  •  Exhibit Hall E
5:30pm-7:30pm
A Novel Post-Transplant High-Dose Cyclophosphamide-Based Regimen to Promote Immune Tolerance After VCA

G. Furtmüller,1 M. Fryer,1 B. Oh,1 S. Ganguly,2 J. Izzi,3 D. Cooney,1 G. Raimondi,1 W. Lee,1 L. Luznik,2 G. Brandacher.1

Poster Session A: Preclinical Immunosuppression and Tolerance  •  Exhibit Hall E
5:30pm-7:30pm
A Prospective Pilot Study Evaluating the Safety and Efficacy of Everolimus for the Prevention of CMV and BK Viral Infection (BKV) in Broadly Sensitized Kidney Transplant Recipients Following Desensitization With IVIG and Rituximab: Interim Analysis

J. Kahwaji,1 S. Louie,1 A. Vo,1 J. Choi,1 M. Toyoda,2 S. Ge,2 P. Wongsaroj,1 A. Peng,1 R. Villicana,1 S. Jordan.1

Poster Session A: Infection  •  Exhibit Hall E